[1]
Purnamayanti, A., Suharjono, S. and Rahmadi, M. 2026. Optimization of ADMET Properties Prediction for Remdesivir, Favipiravir, and their Metabolites Elimination Profiles. Borneo Journal of Pharmacy. 9, 1 (Mar. 2026). DOI:https://doi.org/10.33084/bjop.v9i1.8464.